APA (7th ed.) Citation

Muralidharan, K. K., Kowalski, K. G., Tong, X., Haeberlein, S. B., Rajagovindan, R., & Nestorov, I. (2023). Characterization of exposure–Clinical Dementia Rating–Sum of Boxes relationship in subjects with early Alzheimer’s disease from the aducanumab Phase 3 trials. Journal of pharmacokinetics and pharmacodynamics, 50(1), 45-62. https://doi.org/10.1007/s10928-022-09839-3

Chicago Style (17th ed.) Citation

Muralidharan, Kumar Kandadi, Kenneth G. Kowalski, Xiao Tong, Samantha Budd Haeberlein, Rajasimhan Rajagovindan, and Ivan Nestorov. "Characterization of Exposure–Clinical Dementia Rating–Sum of Boxes Relationship in Subjects with Early Alzheimer’s Disease from the Aducanumab Phase 3 Trials." Journal of Pharmacokinetics and Pharmacodynamics 50, no. 1 (2023): 45-62. https://doi.org/10.1007/s10928-022-09839-3.

MLA (9th ed.) Citation

Muralidharan, Kumar Kandadi, et al. "Characterization of Exposure–Clinical Dementia Rating–Sum of Boxes Relationship in Subjects with Early Alzheimer’s Disease from the Aducanumab Phase 3 Trials." Journal of Pharmacokinetics and Pharmacodynamics, vol. 50, no. 1, 2023, pp. 45-62, https://doi.org/10.1007/s10928-022-09839-3.